American Sleep Apnea Association is hosting its AWAKEtogether Summit virtually!

Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial of Once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

WUN’s Narcolepsy Family Summer Camp – Cancelled

Narcolepsy Interview & Survey Opportunity

NORD Launches Financial Assistance Program for Rare Disease Community Members Impacted by COVID-19

Focus Group Participants Needed to Develop a Pediatric Narcolepsy Patient Reported Outcomes Scale (PN-PROS)

Avadel Pharmaceuticals Completes the REST-ON Phase 3 Pivotal Trial of FT218 for Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

Free Upcoming Webinar Hosted by NORD – A Rare Response: Addressing the COVID-19 Pandemic

Canadian Sleep Society – 2020 Montreal Education Meeting

#WhenIWakeUp – a narcolepsy awareness campaign